JAFA’s latest symposium explores the complex maze of benefits that are potentially available to help meet the increased need for social and health related services in families who have a child with juvenile arthritis with serious physical or other challenges.
In a move warmly welcomed by parents and paediatric rheumatologists alike, the Pharmaceutical Benefits Scheme
JAFA welcomes the Health Minister’s April 27, 2022 announcement of the largest-ever research funding allocation
This ground-breaking Inquiry was instigated by JAFA and conducted by the House of Representatives Standing
This JAFA online symposium shines a light on the link between chronic childhood conditions and mental ill health. Expert speakers outline what is known about the nature and extent of the problem and focus on emerging approaches for reducing the impact of these diseases
on the child and family.
Victoria Allen, the inaugural Chair of Juvenile Arthritis Foundation Australia (JAFA) will retire from the
March 8, 2022 saw an historic landmark for Juvenile Arthritis /childhood rheumatic diseases (JA/CRDs) in
JAFA has long been concerned about the social isolation experiences by children with JA that
The past two years of JAFA’s existence has heralded truly significant milestones for children and
JAFA’s Pre Election Campaign to Change Lives: Stop Pain and Disability in Children with Arthritis.
